Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

EVOTF:US

4.0300 USD 0.3000 6.93%

As of 20:10:02 ET on 03/26/2015.

Snapshot for Evotec AG (EVOTF)

Open: 4.0300 Day's Range: 4.0300 - 4.0300 Volume: 2,200
Previous Close: 4.3300 52wk Range: 3.8000 - 5.5110 1-Yr Rtn: -

Stock Chart for EVOTF

No chart data available.
  • EVOTF:US 4.0300
  • 1D
  • 1M
  • 1Y
4.3300
Interactive EVOTF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for EVOTF

Current P/E Ratio (ttm) -
Estimated P/E(12/2015) 45.2836
Relative P/E vs. SPX -
Earnings Per Share (EUR) (ttm) -
Est. EPS (EUR) (12/2015) 0.0820
Est. PEG Ratio 1.9689
Market Cap (M USD) 530.89
Shares Outstanding (M) 131.73
30 Day Average Volume 73
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 05/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for EVOTF

  • Revenue
  • Net Income (M/EUR)
  • Profit Margin (%)

Company Profile & Key Executives for EVOTF

Evotec AG offers drug research, development, and manufacturing services. The Company offers assay development and screening and compound optimization services to pharmaceutical companies. Evotec also develops drugs on its own for out-licensing.

Werner LanthalerChief Executive OfficerColin BondCFO/Member-Mgmt Board
Mario PolywkaCOO/Member-Mgmt BdCord E DohrmannChief Scientific Officer
More Company Profile & Key Executives for EVOTF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil